Your browser doesn't support javascript.
loading
Real-world efficacy of daclatasvir and asunaprevir with respect to resistance-associated substitutions.
Fujii, Hideki; Umemura, Atsushi; Nishikawa, Taichiro; Yamaguchi, Kanji; Moriguchi, Michihisa; Nakamura, Hideki; Yasui, Kohichiroh; Minami, Masahito; Tanaka, Saiyu; Ishikawa, Hiroki; Kimura, Hiroyuki; Takami, Shiro; Nagao, Yasuyuki; Shima, Toshihide; Itoh, Yoshito.
Afiliação
  • Fujii H; Department of Gastroenterology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 6050981, Japan. fuhideki@koto.kpu-m.ac.jp.
  • Nakamura H; Department of Gastroenterology and Hepatology, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto 6292261, Japan.
  • Minami M; Department of Internal Medicine, Aiseikai Yamashina Hospital, Kyoto 6078086, Japan.
  • Tanaka S; Center for Digestive and Liver Diseases, Nara City Hospital, Nara 6308305, Japan.
  • Ishikawa H; Department of Gastroenterology and Hepatology, Omihachiman Community Medical Center, Shiga 5230082, Japan.
  • Kimura H; Department of Gastroenterology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto 6050981, Japan.
  • Takami S; Department of Gastroenterology, Otsu Municipal Hospital, Otsu 5200804, Japan.
  • Nagao Y; Department of Gastroenterology, Matsushita Memorial Hospital, Moriguchi 5708540, Japan.
  • Shima T; Center of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita 5640013, Japan.
World J Hepatol ; 9(25): 1064-1072, 2017 Sep 08.
Article em En | MEDLINE | ID: mdl-28951778

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: World J Hepatol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: World J Hepatol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão